Shenyang Xingqi Pharmaceutical(300573.SZ) obtained a drug registration certificate.

15:45 06/03/2026

Xingqi Eyedrops (300573.SZ) announced that the company has received the "Drug Registration Certificate" issued by the National Medical Products Administration for Balanced Salt Solution (for irrigation). Balanced Salt Solution (for irrigation) is a sterile isotonic solution used for irrigation of eye tissues. This product is indicated for use as an irrigation solution in ophthalmic surgery, either inside or outside the eye, with a maximum irrigation time of 60 minutes.

Shenyang Xingqi Pharmaceutical (300573.SZ) announced that the company has received the "Drug Registration Certificate" for balanced salt solution (for irrigation) issued by the National Medical Products Administration. Balanced salt solution (for irrigation) is a sterile isotonic solution used for irrigation of ocular tissues. The indications for this product include use in ophthalmic surgery as an intraocular or extraocular irrigation solution, with a maximum irrigation time not exceeding 60 minutes.

Chairman Zheng Jiachun increased his holding of CHOW TAI FOOK (01929) by 30,000 shares at a price of approximately HK$10.76 per share.

Chairman Pan Binze increases his holdings in TEXWINCA HOLD (00321) by 2.76 million shares at a price of approximately 1.21 Hong Kong dollars per share.

CICC: Maintain "Buy" rating on HANSOH PHARMA (03692), raise target price to HK$46.41

Chairman Zheng Jiachun increased his holding of CHOW TAI FOOK (01929) by 30,000 shares at a price of approximately HK$10.76 per share.

Chairman Pan Binze increases his holdings in TEXWINCA HOLD (00321) by 2.76 million shares at a price of approximately 1.21 Hong Kong dollars per share.

CICC: Maintain "Buy" rating on HANSOH PHARMA (03692), raise target price to HK$46.41